Piotr Rutkowski
Impact in
- Gastroenterology top 0.05%
- Gastrointestinal Tumor Research and Treatment
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
Papers in
- Oncology 284
- Cutaneous Melanoma Detection and Management 111
- Cancer Immunotherapy and Biomarkers 95
- CAR-T cell therapy research 77
-
- Sarcoma Diagnosis and Treatment 163
- Co-authors
- W. Ruka (41 shared papers)Dirk Schadendorf (60 shared papers)Zbigniew Nowecki (46 shared papers)Anna M. Czarnecka (100 shared papers)Caroline Robert (45 shared papers)James Larkin (22 shared papers)Reinhard Dummer (38 shared papers)Jean‐Yves Blay (46 shared papers)
- Journals
- Journal of Clinical Oncology (104 papers)Annals of Oncology (70 papers)Cancers (29 papers)European Journal of Cancer (29 papers)European Journal of Surgical Oncology (22 papers)
- Partner nations
- PolandUnited StatesFrance
In The Last Decade
Piotr Rutkowski
691 papers receiving 17.5k citations
Piotr Rutkowski's Hit Papers
Peers
Comparison fields: 5 of 148
- Gastroenterology 3.4k
- Oncology 7.1k
- Pulmonary and Respiratory Medicine 5.5k
- Rheumatology 1.7k
- Immunology 1.9k
Countries citing papers authored by Piotr Rutkowski
This map shows the geographic impact of Piotr Rutkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piotr Rutkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piotr Rutkowski more than expected).
Fields of papers citing papers by Piotr Rutkowski
This network shows the impact of papers produced by Piotr Rutkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piotr Rutkowski. The network helps show where Piotr Rutkowski may publish in the future.
Co-authors
The 25 scholars most cited alongside Piotr Rutkowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 746 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group Hit paper breakdown → | 2012 | 1071 |
| 2 | Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial Hit paper breakdown → | 2018 | 1033 |
| 3 | Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts Hit paper breakdown → | 2011 | 684 |
| 4 | Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2020 | 453 |
| 5 | Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study Hit paper breakdown → | 2013 | 432 |
| 6 | Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS) Hit paper breakdown → | 2016 | 345 |
| 7 | 2017 | 313 | |
| 8 | 2010 | 269 | |
| 9 | 2020 | 254 | |
| 10 | 2019 | 253 | |
| 11 | 2011 | 248 | |
| 12 | 2007 | 208 | |
| 13 | 2012 | 182 | |
| 14 | 2008 | 175 | |
| 15 | 2012 | 163 | |
| 16 | 2019 | 159 | |
| 17 | 2020 | 154 | |
| 18 | 2006 | 142 | |
| 19 | 2011 | 136 | |
| 20 | 2015 | 131 |
About Piotr Rutkowski
Piotr Rutkowski is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Gastroenterology and Rheumatology, having authored 746 papers that have together received 17.8k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (163 papers), Gastrointestinal Tumor Research and Treatment (122 papers), Cutaneous Melanoma Detection and Management (111 papers), Melanoma and MAPK Pathways (107 papers), Cancer Immunotherapy and Biomarkers (95 papers), CAR-T cell therapy research (77 papers), Immunotherapy and Immune Responses (40 papers) and Bone Tumor Diagnosis and Treatments (36 papers). The work is most often cited by research in Gastroenterology (3.4k citations), Oncology (7.1k citations), Pulmonary and Respiratory Medicine (5.5k citations), Rheumatology (1.7k citations) and Immunology (1.9k citations). Piotr Rutkowski has collaborated with scholars based in Poland, United States and France. Frequent co-authors include W. Ruka, Dirk Schadendorf, Zbigniew Nowecki, Anna M. Czarnecka, Caroline Robert, James Larkin, Reinhard Dummer, Jean‐Yves Blay, Maria Dêbiec‐Rychter and Vanna Chiarion‐Sileni. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancers, European Journal of Cancer and European Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.